These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 28554659)

  • 1. Naloxegol, an opioid antagonist with reduced CNS penetration: Mode-of-action and human relevance for rat testicular tumours.
    Andersson H; Mitchard T; Johnson N; Floettmann E
    Toxicol Appl Pharmacol; 2017 Aug; 329():85-95. PubMed ID: 28554659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Species-specific mechanism in rat Leydig cell tumorigenesis by procymidone.
    Murakami M; Hosokawa S; Yamada T; Harakawa M; Ito M; Koyama Y; Kimura J; Yoshitake A; Yamada H
    Toxicol Appl Pharmacol; 1995 Apr; 131(2):244-52. PubMed ID: 7716766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naloxegol: a review of its use in patients with opioid-induced constipation.
    Garnock-Jones KP
    Drugs; 2015 Mar; 75(4):419-25. PubMed ID: 25666542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologic Profile of Naloxegol, a Peripherally Acting
    Floettmann E; Bui K; Sostek M; Payza K; Eldon M
    J Pharmacol Exp Ther; 2017 May; 361(2):280-291. PubMed ID: 28336575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naloxegol: A Novel Therapy in the Management of Opioid-Induced Constipation.
    Jones R; Prommer E; Backstedt D
    Am J Hosp Palliat Care; 2016 Nov; 33(9):875-880. PubMed ID: 26150678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a peripheral and a central acting opioid antagonist on the testicular response to stress in rats.
    Akinbami MA; Taylor MF; Collins DC; Mann DR
    Neuroendocrinology; 1994 Apr; 59(4):343-8. PubMed ID: 8202214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The correlation of serum luteinizing hormone levels with the induction of Leydig cell tumors in rats by oxolinic acid.
    Yamada T; Nakamura J; Murakami M; Okuno Y; Hosokawa S; Matsuo M; Yamada H
    Toxicol Appl Pharmacol; 1994 Nov; 129(1):146-54. PubMed ID: 7974488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rodent Leydig cell tumorigenesis: a review of the physiology, pathology, mechanisms, and relevance to humans.
    Cook JC; Klinefelter GR; Hardisty JF; Sharpe RM; Foster PM
    Crit Rev Toxicol; 1999 Mar; 29(2):169-261. PubMed ID: 10213111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mode-of-action and human relevance framework analysis for rat Leydig cell tumors associated with sulfoxaflor.
    Rasoulpour RJ; Terry C; LeBaron MJ; Stebbins K; Ellis-Hutchings RG; Billington R
    Crit Rev Toxicol; 2014 May; 44 Suppl 2():25-44. PubMed ID: 24832552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulatory effect of luteinizing hormone on the development and maintenance of 5 alpha-reduced steroid-producing testicular interstitial cell tumors in Fischer 344 rats.
    Chatani F; Nonoyama T; Sudo K; Miyajima H; Takeyama M; Takatsuka D; Mori H; Matsumoto K
    Anticancer Res; 1990; 10(2A):337-42. PubMed ID: 2189360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naloxegol for the treatment of opioid-induced constipation.
    Tack J; Corsetti M
    Expert Rev Gastroenterol Hepatol; 2014 Nov; 8(8):855-61. PubMed ID: 25220391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid-induced suppression of rat testicular function.
    Adams ML; Sewing B; Forman JB; Meyer ER; Cicero TJ
    J Pharmacol Exp Ther; 1993 Jul; 266(1):323-8. PubMed ID: 8392556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the effect of Naloxegol on cardiac repolarization: a randomized, placebo- and positive-controlled crossover thorough QT/QTc study in healthy volunteers.
    Gottfridsson C; Carlson G; Lappalainen J; Sostek M
    Clin Ther; 2013 Dec; 35(12):1876-83. PubMed ID: 24238792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism for species-specific induction of Leydig cell tumors in rats by lansoprazole.
    Fort FL; Miyajima H; Ando T; Suzuki T; Yamamoto M; Hamashima T; Sato S; Kitazaki T; Mahony MC; Hodgen GD
    Fundam Appl Toxicol; 1995 Jul; 26(2):191-202. PubMed ID: 7589908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of continuous testosterone exposure on spontaneous and cadmium-induced tumors in the male Fischer (F344/NCr) rat: loss of testicular response.
    Waalkes MP; Rehm S; Devor DE
    Toxicol Appl Pharmacol; 1997 Jan; 142(1):40-6. PubMed ID: 9007032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leydig cell hyperplasia and adenomas in mice treated with finasteride, a 5 alpha-reductase inhibitor: a possible mechanism.
    Prahalada S; Majka JA; Soper KA; Nett TM; Bagdon WJ; Peter CP; Burek JD; MacDonald JS; van Zwieten MJ
    Fundam Appl Toxicol; 1994 Feb; 22(2):211-9. PubMed ID: 8005373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lansoprazole increases testosterone metabolism and clearance in male Sprague-Dawley rats: implications for Leydig cell carcinogenesis.
    Coulson M; Gibson GG; Plant N; Hammond T; Graham M
    Toxicol Appl Pharmacol; 2003 Oct; 192(2):154-63. PubMed ID: 14550749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naloxegol: the first orally administered, peripherally acting, mu opioid receptor antagonist, approved for the treatment of opioid-induced constipation.
    Corsetti M; Tack J
    Drugs Today (Barc); 2015 Aug; 51(8):479-89. PubMed ID: 26380386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Pharmacokinetics and Pharmacodynamics of Naloxegol, a Peripherally Acting ยต-Opioid Receptor Antagonist.
    Bui K; Zhou D; Xu H; Floettmann E; Al-Huniti N
    Clin Pharmacokinet; 2017 Jun; 56(6):573-582. PubMed ID: 28035588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of Leydig cell tumors by lacidipine via up-regulation of the LHRH receptor on Leydig cells in rats.
    Hamada Y; Futamura Y
    J Toxicol Sci; 1998 Feb; 23(1):35-52. PubMed ID: 9513920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.